Search
GSK plc
GSKAdd to Watchlist
50.330USD
-0.080-0.16%
Close 11-06 16:00（ET）
100.84BMarket Cap
12.97P/E TTM
After-hours 19:00 (ET)50.330USD-0.065-0.13%
After-hours 19:00 (ET)GSK plc (GSK) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to GSK plc in the past month.
Buy
2 Strong Buy
4 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
57.040USD+15.21%
GSK Analyst Recommendation Trends
In the current month, GSK has received 4 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. GSK average Analyst price target in the last month is 57.040.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
1
2
2
2
2
4
4
3
3
3
3
3
3
3
3
4
4
4
4
4
4
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
10
10
10
9
10
10
10
10
GSK Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, GSK EPS is projected to reach 0.792 in FY2026Q4, following reported EPS of 1.035 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.16
1.25
1.33
0.79
Actual
1.16
0.29
1.03
--
Surprise
+0.07%
-76.81%
-22.17%
--
FAQs
What is GSK plc's expected revenue for the next quarter?
GSK plc's expected revenue is 11.72B.
What is GSK plc's price target?
Analysts forecast that GSK plc's price target is USD 57.04, with the highest forecast at USD 70.00 and the lowest forecast at USD 37.85.
How have GSK plcGSK's recent earnings per share performed?
The market expectation was USD 1.03, while GSK plcGSK's earnings per share (EPS) for the previous quarter was USD 0.29. EPS for the next quarter is expected at USD 0.79.
What is the analyst rating for GSK plc?
Based on the ratings of GSK plc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.